New metrics for CXL
Refining measurement should lead to better treatment. Read article and watch video.
Leigh Spielberg
Published: Tuesday, May 16, 2017
Progression rate indices are needed that rely less on macroscopic dataSo, what’s new? Dr Touboul finds the development of pachymetry mapping promising. “Using OCT, corneal structure can be analysed by separating stromal changes and epithelial compensation, making this modality very interesting. The dominant method to rate progression is topographical and tomographical analysis,” said Dr Touboul. This is strongly correlated with worsening of keratoconus in terms of biomechanics, retinal image quality as defined by the point spread function, and with quality of life. Indeed, the decision to intervene in order to halt progression surgically is best made based on this morphological metric, he said. But clinicians cannot focus too much on a single metric. Defining keratoconus progression rates requires the analysis of the entire patient’s profile. There is no magic number to determine therapeutic indications, he emphasised. David Touboul: david.touboul@chu-bordeaux.fr
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Piecing Together a Solution
What is the best use of robotics and AI in cataract and refractive surgery?
Advances in Toric IOL Alignment
Biomorphometric approaches offer high precision and increase efficiency.
Library of Short Videos Complements Educational Offerings
Tackling Waste in Retinal Surgery
Reducing waste from intravitreal injections is an achievable goal.
The Modern Era of Refractive Surgery
New technologies for screening and treatment qualify more patients for intervention.
Monofocal Plus Finding the Balance
Enhanced monofocals may be the future standard of care in cataract patients.
Growing Options Optimise Outcomes in Cataract Surgery
Understanding the promise and potential problems of AI-based IOL formulas.